סודיום כלוריד % 0.9 לעירוי לתוך הוריד BP İsrail - İbranice - Ministry of Health

סודיום כלוריד % 0.9 לעירוי לתוך הוריד bp

teva medical marketing ltd. - sodium chloride - תמיסה לאינפוזיה - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

סודיום כלוריד % 0.9 לעירוי לתוך הוריד BP İsrail - İbranice - Ministry of Health

סודיום כלוריד % 0.9 לעירוי לתוך הוריד bp

teva medical marketing ltd. - sodium chloride - תמיסה לאינפוזיה - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

סודיום כלוריד % 0.9 לעירוי לתוך הוריד BP İsrail - İbranice - Ministry of Health

סודיום כלוריד % 0.9 לעירוי לתוך הוריד bp

teva medical marketing ltd. - sodium chloride - תמיסה לאינפוזיה - sodium chloride 0.9 %w/v - sodium chloride

פניצילין G סודיום 10 M.U İsrail - İbranice - Ministry of Health

פניצילין g סודיום 10 m.u

teva israel ltd - benzylpenicillin sodium - אבקה להכנת תמיסה לזריקה - benzylpenicillin sodium 10 mu/vial - benzylpenicillin - benzylpenicillin - infections due to penicillin - sensitive microorganisms.

לוסק 10 מ"ג İsrail - İbranice - Ministry of Health

לוסק 10 מ"ג

abic ltd. - omeprazole 10.0 mg - capsules - omeprazole - - acute duodenal ulcer. - acute gastric ulcer. - helicobacter pylori-associated peptic ulcer disease in combination with antibiotics. - reflux esophagitis:• treatment;• long-term management;• maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. - severe reflux esophagitis in children from one year of age and older • maintenance treatment for the prevention of relapse in patients with poorly responsive peptic ulcer.• zollinger-ellison syndrome.• treatment and prevention of nsaid – associated duodenal and gastric ulcers or erosions in high risk patients.

לוסק 10 מ"ג İsrail - İbranice - Ministry of Health

לוסק 10 מ"ג

abic ltd. - omeprazole 10.0 mg - capsules - omeprazole - - acute duodenal ulcer. - acute gastric ulcer. - helicobacter pylori-associated peptic ulcer disease in combination with antibiotics. - reflux esophagitis:• treatment;• long-term management;• maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. - severe reflux esophagitis in children from one year of age and older • maintenance treatment for the prevention of relapse in patients with poorly responsive peptic ulcer.• zollinger-ellison syndrome.• treatment and prevention of nsaid – associated duodenal and gastric ulcers or erosions in high risk patients.

רימודולין 5 מגמל İsrail - İbranice - Ministry of Health

רימודולין 5 מגמל

rafa laboratories ltd - treprostinil as sodium - תמיסה להזרקה - treprostinil as sodium 5 mg/ml - treprostinil - treprostinil - remodulin is indicated as a continuous subcutaneous infusion or intravenous infusion for the treatment of primary pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue disorders. pulmonary hypertension associated with congenital systemic to pulmonary shunts.

רימודולין 2.5 מגמל İsrail - İbranice - Ministry of Health

רימודולין 2.5 מגמל

rafa laboratories ltd - treprostinil as sodium - תמיסה להזרקה - treprostinil as sodium 2.5 mg/ml - treprostinil - treprostinil - remodulin is indicated as a continuous subcutaneous infusion or intravenous infusion for the treatment of primary pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue disorders. pulmonary hypertension associated with congenital systemic to pulmonary shunts.

תמיסת דקסטרוז % 10 להזרקה İsrail - İbranice - Ministry of Health

תמיסת דקסטרוז % 10 להזרקה

teva medical marketing ltd. - glucose as monohydrate - תמיסה להזרקה - glucose as monohydrate 10 % - glucose - glucose - as intravenous injection: dextrose 10 % injection is indicated as a source of water and calories. as parenteral nutrient: dextrose 10 % injection is indicated as a caloric component in parenteral nutrition regimen. it is used with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1) the alimentary tract cannot should not be used. 2) gastrointestinal absorption of protein is impaired, or 3) metabolic requirements for protein are substantially increased, as extensive burns.